General Information of Drug (ID: DMB5JWX)

Drug Name
Pegadricase Drug Info
Indication
Disease Entry ICD 11 Status REF
Gout FA25 Phase 1 [1]
Cross-matching ID
PubChem CID
86278331
CAS Number
CAS 1040753-26-1
TTD Drug ID
DMB5JWX

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Drug(s) Targeting Uric acid (URA)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Pegloticase DMCLR6G Gout FA25 Approved [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Uric acid (URA) TTZ1SWF NOUNIPROTAC Modulator [2]

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800018169)
2 Uricase formulated with polyethylene glycol (uricase-PEG 20): biochemical rationale and preclinical studies. J Rheumatol. 2002 Sep;29(9):1942-9.
3 Mullard A: 2010 FDA drug approvals. Nat Rev Drug Discov. 2011 Feb;10(2):82-5.